| Residue-by-residue view of in vitro FUS granules that bind the C-terminal domain of RNA polymerase II KA Burke, AM Janke, CL Rhine, NL Fawzi Molecular cell 60 (2), 231-241, 2015 | 813 | 2015 |
| Pathogenic variants that alter protein code often disrupt splicing R Soemedi, KJ Cygan, CL Rhine, J Wang, C Bulacan, J Yang, ... Nature genetics 49 (6), 848-855, 2017 | 196 | 2017 |
| Hereditary cancer genes are highly susceptible to splicing mutations CL Rhine, KJ Cygan, R Soemedi, S Maguire, MF Murray, SF Monaghan, ... PLoS genetics 14 (3), e1007231, 2018 | 54 | 2018 |
| The effects of structure on pre-mRNA processing and stability R Soemedi, KJ Cygan, CL Rhine, DT Glidden, AJ Taggart, CL Lin, ... Methods 125, 36-44, 2017 | 52 | 2017 |
| Mutational bias and the protein code shape the evolution of splicing enhancers S Rong, L Buerer, CL Rhine, J Wang, KJ Cygan, WG Fairbrother Nature communications 11 (1), 2845, 2020 | 23 | 2020 |
| Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness SF Monaghan, D Banerjee, CS Chung, J Lomas-Neira, KJ Cygan, ... Molecular Medicine 24, 1-7, 2018 | 22 | 2018 |
| Future directions for high‐throughput splicing assays in precision medicine CL Rhine, C Neil, DT Glidden, KJ Cygan, AM Fredericks, J Wang, ... Human mutation 40 (9), 1225-1234, 2019 | 17 | 2019 |
| Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genes CL Rhine, C Neil, J Wang, S Maguire, L Buerer, M Salomon, ... PLoS genetics 18 (1), e1009884, 2022 | 15 | 2022 |
| Residue-by-residue view of KA Burke, AM Janke, CL Rhine, NL Fawzi Vitro FUS Granules that Bind the C-Terminal Domain of RNA Polymerase II. Mol …, 2015 | 13 | 2015 |
| Defective splicing of the RB1 transcript is the dominant cause of retinoblastomas KJ Cygan, R Soemedi, CL Rhine, A Profeta, EL Murphy, MF Murray, ... Human genetics 136, 1303-1312, 2017 | 8 | 2017 |
| CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods N Null, S Jain, C Bakolitsa, SE Brenner, P Radivojac, J Moult, S Repo, ... Genome Biology 25 (1), 1-46, 2024 | 3 | 2024 |
| Abstract LB169: Using a global reporter on transcript abundance to identify a selective inhibitor of Nrf2 signaling in KEAP1-mutant non small cell lung cancer TJ Read, L Damon, R Yoo, C Grochala, C Liechty, C Rhine, J Rimel, ... Cancer Research 84 (7_Supplement), LB169-LB169, 2024 | | 2024 |
| Enhancer RNA profiles predict sensitivity to a novel GPX4 inhibitor T Read, D Simpson, J Rimel, C Rhine, C Pham, C Liechty, E Martin, ... Cancer Research 83 (7_Supplement), 4913-4913, 2023 | | 2023 |
| Identification of novel GPX4 inhibitors using global transcriptional reporters T Read, Z Winigrad, A Goliaei, C Liechty, C Grochala, L Damon, ... Cancer Research 83 (7_Supplement), 2755-2755, 2023 | | 2023 |
